Cytotoxic T lymphocytes (CTL) can recognize antigenic peptides bound in a groove formed by the od and ol2 domains of the heterodimeric major histocompatibility complex class I molecule. Proper assembly, transport, and stability of functional class I molecules is thought to require 32 microglobulin (32m), the light chain of the class I heterodimer. We show here that the requirement for 32m is not absolute. 32m-cells can be stained by the D b oO domain-specific B22-249.1 monoclonal antibody, which detects a conformation-dependent epitope. Furthermore, 32m-Con A blast target cells can be lysed by alloreactive CTL, even in serum-free conditions. Contrary to previous reports, the expression of low levels of conformed D b heavy (H) chains is a property of both normal and transformed 32m-cells. Finally, we present evidence that a subset of properly conformed H chains, free of 3zm, may have almost equal representation on 32m + and 32m-cells.
M
HC class I molecules are composed of a 45-kD polymorphic H chain noncovalently associated with 32 microglobulin (~2m) 1. Previous studies have suggested that 32m is critical for the normal function of class I molecules. In mutant cells that are unable to synthesize 32m, most class I H chains accumulate intraceUularly and are degraded (1, 2) . Some class I H chains, such as D b, reach the cell surface in 32m-deficient cell lines such as the 32m-R1E cell line (C58 origin, H-2k), which had been transected with the D b gene (R1E/D b) (1) . Cell surface expression of D b in 32m-tumor cells could be detected with the 28-14-8s mAb, that reacts with the c~3 domain of the D b molecule. However, the levels of cell surface D b expression were reduced in the 32m-cells compared with the same cells supertransfected with 32m (R1E/Db/32m). More importantly, the peptidebinding domains of D b molecules on the surface of R1E/D b cells apparently assume an altered conformation, as shown by their failure to react with mAb specific for the cd (e.g., B22-249.1) or or2 domains of D b (1, 3) . Furthermore, alloreactive or antigen-speeific/class I-restricted cytotoxic T cells specific for D b failed to react with R1E/D b cells, suggesting an important role for 32m in generating class I complexes visible to the TCR. These experiments suggested that 32m plays an obligatory role in inducing and/or maintaining a functional conformation of class I molecules.
We have examined cell surface class I expression on cells from mice homozygous for a targeted mutation in their 32m
1 Abbreuiation used in this paper: 32m, 3z microglobulin.
gene. We previously reported (4) preliminary findings that cells from these mice fail to synthesize 32m, and have essentially no serologically detectable levels of K b or Qa2 class I molecules on their surface. However, low levels (about 1/20th the level found on 32m + cells) of D b molecules were detected on freshly isolated T cells from 32m-mice by staining with Db-specific mAbs 28-14-8s, B22-249.1, and 27-11-13s. Furthermore, 32m-Con A blasts could be lysed, albeit inefficiently, by populations of alloreactive, H-2 bspecific CTL. Our findings that 32m-cells can be stained by al-specific B22-249 mAb, and that 3~m-Con A blast target cells can be lysed by alloreactive CTL, contrast with previous reports that 32m-RIE/D b tumor cells are neither stained by B22-249.1 mAb, nor are lysed by alloreactive CTL.
Our earlier studies were performed in serum-containing medium. Serum contains free 32m that could potentially bind to free class I H chains, resulting in a functional conformation of the molecules (5). Furthermore, 32m shed from the CTL used in the functional experiments might have transferred onto the target cells. In the present paper, we provide direct evidence that functional, conformed free dass I H chains exist on the surface of 32m-cells in the absence of 32m. The implications of these findings for the normal function of class I molecules are discussed.
Radiation Bone Marrow Chimeras. Bone marrow was prepared from female fl2m-H-2 k homozygous mice (5 mo-old) resulting from the intercross of the 4th backcross generation of B10.BR x (B6 x 129)F1, and was depleted of T cells by treatment with antiThyl.2 (JIJ) plus complement. Ten million T-depleted marrow cells were injected into female B10.BR mice (3-5 too-old) irradiated (980 tad from a 137Cs source) '~2 h earlier. To prevent rejection of the class I-deficient marrow grafts by NK cells, all recipients were depleted of NKI.1 + cells by intraperitoneal injection with 200/xg PK136 1 d earlier (7) . Spleen cells were harvested for analysis 12 wk later.
Immunofluorescent Staining Analysis. Lymph node suspensions from individual mice or tumor cells were stained at 106 cells/25 pl for 20 rain at 4~ in either PBS, 5% FCS, 0.2% NaN3 (medium containing B2m), or PBS, 14 /~g/ml ~-galactosidase (Sigma Chemical Co., St. Louis, MO), and 0.2% NaN3 (/32m-free staining media). Between stains, cells were washed two times. After the final wash, cells were fixed in 1% paraformaldehyde and stored, foil wrapped, at 4~ until analysis. Analysis was performed on a FACStar +| flow cytometer. Typically, 20,000 cells per sample were analyzed.
Cytolysis Analysis. Primary MLC were established essentially as described (8) . Briefly, 25 x 106 responder splenocytes and 25 x 106 stimulator splenocytes (receiving 3,000 rad from a 137Cs source) were cultured together in 20 ml of RP-5 in upright T-25 flasks (Coming Glass Works, Corning, NY) for 5 d and then harvested for cytolysis assay. Cells harvested on day 9 or 10 from 1 ~ MLC were reestablished in 2 ~ MLC (2-3 x 106 responder cells/culture) with fresh stimulator cells (25 x 106 cells/culture) and cultured for 4 d before harvesting for assay. The cytolysis assay was performed essentially as described (8) either in RP-5 or AIM-V, as indicated. For target cell preparation, splenocytes were cultured for 2 or 3 d in 24-well plates (Falcon Plastics, Lincoln Park, NJ) at 2 x 106 cells/ml with 2 pg/ml Con A (when culturing in RP-5), and 0.33 pg/ml Con A (when culturing in AIM-V).
Immunomagnetic Depletion of B Cells. B2m-spleen cells were stained with affinity-purified, fluorescein-conjugated, goat antimouse Ig antibody in ~zm-free staining media for 20 min at 4~ washed two times, then treated with sheep anti-fluoresceinconjugated magnetic beads (Advanced Magnetics) for 30 min at 4~ with gentle rocking. Ig + (and hence, magnetic) cells were removed by exposing the cell suspension for 15 min at room temperature to a strong magnetic field using a Biomag device (Advanced Magnetics). Nonimmob'dized cells were recovered and passed a second time through the Biomag device to remove any remaining Ig § cells. Recovered cells were washed into AIM-V medium before the cytolysis assay.
Antibody Plus Complement Depletion. CTL populations were resuspended at 20 x 106 cells/ml in RP-5, and the optimal dilution of mAb and a mixture of rabbit and guinea pig complement. After incubation at 37~ for 40 min, viable cells were recovered by passage over a ficoll gradient and washed into the appropriate media.
Results
Polyclonal CTL populations specific for H-2 b were generated in MLC, in which BALB/c (H-2 a) or B10.BR (H-2 k) spleen cells were stimulated with B6 (H-2 b) stimulator spleen cells. In most cases, the CTL were restimulated with B6 spleen cells before assaying their activity. The CTL were tested for their capacity to lyse Con A blast targets from H-2b-type ~2m-or ~2m + mice ( Fig. 1 ). Corroborating our earlier study, B2m-target cells were lysed by the CTL, although substantially less efficiently than were ~/2m + target cells. To achieve equivalent lysis of ~2m-target cells, 50 times more CTL from primary MLC were usually required than for lysis of/3zm + target cells (Fig. 1 A) . CTL from secondary MLC appeared capable of more efficient relative lysis of B2m-target cells, since only 10-20 times more CTL from secondary MLC were typically required for lysis of B2m-target cells than for lysis of B2m + target cells ( Fig.  1 B) . There was no significant lysis of syngeneic (BALB/c or B10.BK)/32m + target cells by any of these CTL, demonstrating their specificity.
Previous studies have shown that bovine B2m, present in FCS, can associate with class I H chains on cells cultured in serum-containing medium (5). It was therefore possible that lysis of ~2m-cells by CTL depended on the binding of serum ~2m to free class I H chains on the surface of/32m-cells. To test this possibility, we compared experiments performed in FCS-containing medium with those performed in AIM-V serum-free medium. The two media were used for generating target cell blasts and for the cytolysis assay. Because AIM-V medium failed to support the generation of high levels of CTL activity in MLC, the CTL were generated in FCS-containing medium, and were washed extensively in AIM-V medium before the cytolysis assay. As shown in Fig.  1 , A and B, a similar extent of lysis of ~2m-target cells was observed in FCS-containing medium as in AIM-V serum-free medium, indicating that serum ~2m is not necessary for lysis of/32m-cells by CTL.
The lysis of ~2m-target cells is not mediated by MHC class II (MHC-II)-specific CTL, because T-blast target cells, which do not express MHC-II in the mouse, were employed for all of these experiments. To rule out the possibility that contaminating B cell blasts in the Con A blast preparation are responsible for the observed lysis, we employed as target cells B2m-Con A blasts that had been depleted of class II + B cells before culture, by immunomagnetic separation with anti-Ig coated magnetic beads. These target cells were lysed as efficiently as target cells from which B cells had not been specifically depleted (Fig. 1 B) . The effector cells that lyse H-2 b, 32m-target cells were typed for expression of cell surface markers by treating the effector cell population with specific mAb and complement before the cytolysis assay. Treatment of the population with anti-CD8 mAb plus complement strongly reduced lysis of B2m-cells, whereas treatment with anti-CD4 plus complement or anti-NKl.1 plus complement had no effect. Therefore, lysis of 32m-cells by these cytolytic cells is mediated by CTL of the conventional CDS+CD4-NKI.1 -phenotype (Fig. 2) . Although our previous results indicate that NKI.I+CDS-NK cells can also lyse 3zm-target cells (9), To directly test whether the B10.A(18R) anti-B6 CTL recognize D b on 32m-target cells, antibody blocking experiments were performed. These experiments employed the mAb B22-249.1, which recognizes the cd domain of D b. Binding of B22-249.1 mAb has been used as evidence that the cd domain of D b is in a properly folded conformation (1, 3, 10) . To minimize any sources of soluble 32m in the experiment, the target cells were generated by culture in AIM-V medium, the assay was performed in AIM-V medium, and purified B22-249.1 IgG was employed. Nonsaturating effector/target ratios were used, based on a preliminary titration experiment (Fig. 4 A) . As shown in Fig. 4 B, B22-249.1 IgG, in a dose-dependent manner, inhibited lysis of both 32m + and/32m-target cells by the B10.A(18R) anti-B6 CTL. The antibody had no effect on lysis of H-2 k targets by B10.A(18R) anti-B10.BR CTL, demonstrating the specificity of the effect. These results demonstrate directly that allospecific CTL can recognize D b molecule on 32m-cells. The results further suggest that the D b molecules recognized are in a folded conformation detected by the B22-249.1 mAb.
Although the previous experiments were performed under conditions minimizing sources of soluble B2m, it remained possible that B2m from the CTL themselves was transferred to the target cells during the cytolysis assay. To address this possibility, we sought to employ a population of CTL that were Bum-. B2m-mice are deficient in CD8 + CTL. However, differentiation of B2m-hematopoietic stem cells in irradiated Bum + mice leads to the efficient differentiation of CD8 + CTL precursors under the influence of the host thymus (Bix and Raulet, manuscript submitted for publication). Therefore, to generate B2m-, H-2 k CTL precursors, we produced radiation chimeras by inoculating irradiated B10.BR mice with bone marrow cells from H-2 k, B2m-donors. 13 wk later, spleen cells from the reconstituted chimeras and control B10.BR mice were isolated and stimulated twice consecutively in MLC with B6 spleen cells to generate anti-H-2 b CTL. To deplete the minor fraction of radioresistant hematopoietic cells of host (class I +) origin often found in radiation chimeras, the chimeric CTL population was depleted of residual radioresistant B2m+, H-2 k cells by treatment with anti-H-2 k mAb (16-1-2n) plus complement on the day of the cytolysis assay. As before, the cytolysis assay and target cell cultures were performed in AIM-V medium. Thus, essentially no B2m was present in this experiment.
As shown in Fig. 5 B, the B2m-, anti-H-2 k CTL lysed Bzm-, H-2 b target cells. Comparing dose-response curves, the lysis of B2m-versus that of B2m + target cells by the B2m-CTL was similar to that mediated by the B2m + (B10.BR) CTL, although the latter population was somewhat more potent (compare Fig. 5, A and B ). The depletion of residual H-2 k+ cells from the chimeric CTL population made no difference in the dose-response curves. Depletion of H-2 k cells from the control B10.BR CTL population eliminated CTL activity, demonstrating the effectiveness of the antibody plus complement treatment. These results suggest that lysis of B2m-H-2 b target cells by aUospecific CTL does not depend upon B2m.
The data in the previous experiments do not distinguish whether most anti-H-2 b CTL in the populations lyse B2m-, H-2 b targets poorly, or alternatively, that only a subset of anti-H-2 b CTL lyse B2m-targets. As one means of addressing this question, we generated CTL by stimulating B10.BR responder spleen cells twice consecutively with either 32m-or B2m + H-2 b stimulator spleen cells in MLC. Although significant CTL activity was not induced after only one round of stimulation with Bzm-cells (4), significant activity was usually evident after two or more rounds of stimulation (Fig. 6 ). These effector cells lysed B2m + and B2m-H-2 b targets with nearly equal efficiency, but did not lyse B10.BR target cells (Fig. 6 B) . As in previous experiments, the CTL raised against B2m +, H-2 b stimulator cells lysed B2m + target cells much better than they lysed B2m-target cells. These data suggest that a subset of anti-H-2 b CTL lyse Bum + and Bum-target cells with nearly equal efficiency.
To examine the expression of serologically detected class I epitopes on the B2m-cells, we stained lymph node cells with a conformation-dependent anti-class I antibody (B22-249.1), and examined them by flow cytometry. To ensure that no Bum was present in the experiment, we employed purified antibody preparations, harvested the cells in serum-free medium, and stained the cells in medium that contained To our surprise, B2m-RIE/D b cells also stained specifically with B22-249.1 mAb. The absolute intensity of staining was similar to that of B2m-lymph node cells. By comparison, the B2m + variant of these cells, R1E/Db/~2m, stained more intensely than B2m + lymph node cells. Considering that the tumor cells are larger than lymph node cells, it appears that the/32m-tumor cells may express a lower density of D b on their surface than the ~2m-lymph node cells.
Discussion
Our results suggest that the D b molecule can assume a functional conformation in the absence of ~2m. This conclusion is based on the findings that/3zm-cells were stained by the conformation-dependent B22-249.1 mAb in serumfree medium, and were lysed by allospecific ~2m-CTL in serum-free medium. Furthermore, the Db-specific lysis of ~2m-cells could be blocked with the conformationdependent B22-249.1 mAb.
Our results with the R1E/D b cell line contrast with previous results suggesting that this cell line fails to present properly conformed H chain at the cell surface (1). The different results are not due to the use of different reagents, because the earlier studies, like ours, employed the B22-249.1 mAb. It is likely that previous studies with R1E/D b were not sufficiently sensitive to detect correctly conformed D b on the cells, since we find that successful detection requires a highly sensitive staining protocol Although R1E/D b stains relatively weakly compared with the staining of K1E/Db/~2m, the results indicate that the expression of low levels of conformed D b H chains is a property of both normal and transformed B2m-cells.
We further find that a subset of allospecific CTL, generated by multiple stimulations with ~zm-cells, lyse ~2m-and B2m + cells equally well. This observation, taken together with other findings, is most simply explained by assuming that these effectors recognize a set of properly conformed H chains, free of B2m, that are roughly equally represented on B2m + and/32m-cells. Whether these free H chains are associated with peptides is not known. Evidence for CTL recognition of peptide-free, B2m-containing class I molecules has been reported (11). However, it seems unlikely that H chains free of both peptides and B2m would maintain a functional conformation at the cell surface.
We favor an alternative possibility, that is suggested by recent findings that in the absence of/~2m, free D b H chains incubated with physiologically relevant, nonamer peptides assume a conformation reactive with B22-249.1 mAb (3). High (micromolar) concentrations of peptide were required to observe this effect. Nonetheless, it is possible that some cellular peptides bind to free D b H chains in ~2m-cells tightly enough to stabilize the properly folded conformation for transport to the cell surface. Such complexes might be expected to have a short half-life in the absence of B2m. Alternatively, a subset of peptides may bind free H chains very tightly, resulting in stable complexes at the cell surface.
A great deal of recent effort has been devoted to attempts to understand the assembly of class I H chains with antigenic peptides, and ~2m in vivo (3, (11) (12) (13) (14) . An important question is whether peptides associate with H chain before or after B2m, and the relative contribution of peptide binding and ~2m binding to the stability of the trimolecular complex. Our results raise the possibility that, at least in some instances, peptides may bind H chains in the absence of ~2m with sufficient affinity to establish a functionally conformed molecule on the cell surface.
